CAS No. 372117-52-7

Morpholine,4-[[4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinyl]carbonyl]-

Catalog No.: 2079874
Name: Morpholine,4-[[4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinyl]carbonyl]-
CAS: 372117-52-7
Formula: C22H28ClN5O4

Filed under: Pyrrolidinyl, 4-Methoxyphenyl, Hydroxymethyl

Inquire about this product → | Safety data

About Morpholine,4-[[4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinyl]carbonyl]-

Morpholine,4-[[4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinyl]carbonyl]- is a chemical compound registered under CAS number 372117-52-7, with the molecular formula C22H28ClN5O4 and a molecular weight of about 461.95 g/mol. 9CMX supplies Morpholine,4-[[4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinyl]carbonyl]- for laboratory research and bulk production; product code 2079874. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 372117-52-7
Molecular Formula: C22H28ClN5O4
Molecular Weight: 461.95 g/mol

Related Keywords

amino

carbonyl

morpholine

pyrimidinyl

pyrrolidinyl

methoxyphenyl

hydroxymethyl

Pyrrolidinyl

Pyrimidinyl

Morpholine

2H-Pyran-2-carboxaldehyde,2,5-bis[(1,1-dimethylpropyl)thio]-3,4-dihydro-,(2,4-dinitrophenyl)hydrazone

2-Cyclohexen-1-ol, 4-[(diphenylamino)oxy]-, (1R,4S)-rel-

2H-Pyran-2-one, 3,4-dihydro-6-(4-methoxyphenyl)-5-(4-phenoxybutyl)-

2H-Pyran-2-carboxaldehyde, 2,5-diethoxy-6-(ethylthio)tetrahydro-

2-Cyclohexen-1-ol,2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-ethyl-, (1S)-

2H-Pyran-2-ol,tetrahydro-4-methyl-6-(2-methylpropyl)-2-(trifluoromethyl)-,(2R,4S,6R)-rel-

488863-63-4

2-Butenoic acid, 3-[(2-aminophenyl)amino]-, propyl ester

2-Cyclohexen-1-ol, 2-methyl-3,5-bis(1-methylethenyl)-, (1S,5S)-

2-Cyclohexen-1-ol, 3-methyl-2-[3-(phenylthio)propyl]-, 4-nitrobenzoate

2H-Pyran-2-carboxamide,N-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)tetrahydro-

2H-Pyran-2-carboxaldehyde, 3,4-dihydro-2,5-bis[(2-methylpropyl)thio]-

Acetic acid, 2-[[6-(trifluoromethyl)thiazolo[4,5-b]pyridin-2-yl]thio]-, methyl ester

866149-79-3

2-Butenoic acid, 3-(butoxymethoxy)-2-(2,2-dichloroethenyl)-, ethyl ester,(E)-

2-Cyclohexen-1-ol,2-methyl-5-(1-methylethenyl)-1-(2-methylpropyl)-6-(2-propenyl)-,(1R,5R,6R)-

2H-Pyran-2-carboxylic acid, 3,6-dihydro-4-methyl-, butyl ester

2H-Pyran-2-ol, 3-chlorotetrahydro-, acetate, cis-

2H-Pyran-2-methanol,5-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-6-(2Z)-2-dodecenyltetrahydro-,(2R,5R,6R)-

2H-Pyran-2,6(3H)-dione,3-[(dimethylamino)methylene]-4-(4-methoxyphenyl)-

105641-50-7

2H-Pyran-2,6(3H)-dione,4-methyl-3-[1-[(4-methylphenyl)amino]ethylidene]-, (Z)-

2H-Pyran-2-ol, 5-chlorotetrahydro-

2-Cyclohexen-1-ol, 2-(2-methoxyethyl)-3-methyl-

2-Cyclohexen-1-ol, 6-(phenylthio)-, 4-nitrobenzoate, trans-

2-Cyclohexen-1-one, 2-(cyclohexylcarbonyl)-3,6,6-trimethyl-

2H-Pyran-2,6(3H)-dione,5-acetyl-4-methyl-3-[1-(phenylamino)ethylidene]-, (Z)-

106104-61-4

2-Butenoic acid, 3-[(methoxyphenylphosphinyl)oxy]-, ethyl ester, (Z)-

2H-Pyran-2-one, 3-(4,4-dimethyl-1-oxopentyl)-4-hydroxy-6-methyl-

2-Cyclohexen-1-ol,3-(3-butenyl)-2,4-dimethyl-5-(1-methylethenyl)-4-(2-propenyl)-,(1S,4R,5S)-

2-Butenoic acid, 3-(butylamino)-, ethyl ester, (2Z)-

2H-Pyran-2-one, 3-(1H-1,5-benzodiazepin-4-yl)-4-hydroxy-6-methyl-

4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-5-amine

866216-20-8

2-Butenoic acid, 3-(2-furanyl)-4-phenoxy-, (E)-

2-Cyclohexen-1-ol, 2-iodo-4,4-dimethyl-, (1R)-

2-Cyclohexen-1-one, 2-[(trimethylsilyl)methyl]-

2H-Pyran-2-amine, tetrahydro-N-phenyl-

2H-Pyran-2-acetic acid,6-[(1R,2E,4E,6R,8E)-9-bromo-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-methoxy-3-methyl-2,4,8-nonatrienyl]tetrahydro-2,4-dimethoxy-,(2S,4R,6R)-

2-Cyclohexen-1-ol, 2-phenyl-, benzoate